The FDA-approved GLP-1 receptor agonists are exenatide (Byetta, Bydureon), liraglutide (Victoza, Saxenda), lixisenatide (Adlyxin), dulaglutide (Trulicity), semaglutide (Ozempic, Wegovy, Rybelsus), and efpeglenatide (Eperzan)
Growth hormone also promotes local IGF-1 signaling, which further contributes to tissue regeneration and structural strength
Healthletic BPC-157 is increasingly used as part of athletic recovery stacks due to its non-invasive format and science-informed formulation
Experimental studies have shown that methylation activity is lower in hypothyroidism, and higher in hyperthyroidism
Data Availability: All relevant data are within the paper and its Supporting Information files
& Hammami, R